Keros Therapeutics, INC 8-K filings

NASDAQ

28 Feb 2024

KROS

8-K: Keros Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update

Keros Therapeutics announced its fourth quarter and full year 2023 financial results, highlighting clinical progress and a strengthened cash position.